These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7285025)

  • 21. Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
    Erhardt LR
    Ital Heart J; 2003 May; 4 Suppl 2():27S-33S. PubMed ID: 14635367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The post-MI role of hemodynamic monitoring.
    Parmley WW
    Hosp Pract (Hosp Ed); 1982 May; 17(5):169-75. PubMed ID: 7200948
    [No Abstract]   [Full Text] [Related]  

  • 23. Usefulness and limitations of vasodilator therapy in the treatment of pump failure complicated by acute myocardial infarction.
    Saito M; Hiramori K; Haze K; Sumiyoshi T; Fukami K; Goto Y
    Jpn Circ J; 1984 Apr; 48(4):340-9. PubMed ID: 6716634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM; Hare JM; Loh E; Gauthier DF; Colucci WS
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of intravenous nitroglycerin on hemodynamics of congestive heart failure.
    Pitt WA; Friedman RG; Gross SA; Glassman J; Keating EC; Mazur JH
    Angiology; 1982 May; 33(5):294-301. PubMed ID: 6805373
    [No Abstract]   [Full Text] [Related]  

  • 27. The use of vasodilator agents in the treatment of heart failure.
    Lloyd EA
    S Afr Med J; 1979 Nov; 56(20):787-95. PubMed ID: 159502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of inhibition of lipolysis on heart failure following acute coronary occlusion in the dog.
    Kjekshus JK
    Cardiovasc Res; 1974 Jan; 8(1):73-80. PubMed ID: 4819492
    [No Abstract]   [Full Text] [Related]  

  • 30. BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential.
    Burger MR; Burger AJ
    Curr Opin Investig Drugs; 2001 Jul; 2(7):929-35. PubMed ID: 11757793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concepts of peripheral circulatory control: implications for vasodilator therapy in heart failure.
    Rubin SA; Swan HJ
    Cardiovasc Clin; 1984; 14(3):19-29. PubMed ID: 6144389
    [No Abstract]   [Full Text] [Related]  

  • 32. [Application of vasodilators for acute myocardial infarction (author's transl)].
    Tamura K
    Kokyu To Junkan; 1976 Sep; 24(9):755-63. PubMed ID: 824700
    [No Abstract]   [Full Text] [Related]  

  • 33. [Value and limits of the intracardiac pressure determination for the evaluation of heart function in recent myocardial infarct].
    Bourdarias JP; Bardet J; Kahn JC; Normand JP; Mathivat A
    Ann Med Interne (Paris); 1974 Oct; 125(10):771-6. PubMed ID: 4451309
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long-term use of vasodilator agents].
    Luomanmaki K; Frick MH
    Duodecim; 1982; 98(2):139-49. PubMed ID: 7060511
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasodilators in left ventricular failure.
    Camerini F; Mestroni L; Neri R; Humar F
    G Ital Cardiol; 1984 Sep; 14(9):685-93. PubMed ID: 6510623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of vasodilating agents in the treatment of chronic heart failure.
    Gunnar RM
    Angiology; 1980 Aug; 31(8):526-32. PubMed ID: 7001960
    [No Abstract]   [Full Text] [Related]  

  • 37. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S; Martinez J; Lam W; Levy PS; Rosen KM
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of intravenous nitroglycerin in the coronary care unit.
    Cody R
    Angiology; 1982 May; 33(5):313-8. PubMed ID: 6805375
    [No Abstract]   [Full Text] [Related]  

  • 39. [Vasodilators in cardiac insufficiency].
    Bernardi LF; de Nononay NC
    Arq Bras Cardiol; 1980 Jan; 34(1):53-62. PubMed ID: 7406738
    [No Abstract]   [Full Text] [Related]  

  • 40. Postural influences on the hemodynamic responses to vasodilating drugs in congestive heart failure.
    Ren JH; Unverferth DV; Magorien RD; Leier CV
    Arch Intern Med; 1985 Apr; 145(4):641-4. PubMed ID: 3985726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.